COMPARISON OF COMBINATION SUBCUTANEOUS INFLIXIMAB AND AN IMMUNOMODULATOR VERSUS SUBCUTANEOUS INFLIXIMAB MONOTHERAPY: POST-HOC ANALYSIS OF A RANDOMISED CLINICAL TRIAL

Sangwook Yoon  1     Dong-Hyeon Kim  1     Fraser Cummings  2     Peter Irving  3     Geert R. D'Haens  4     Shomron Ben-Horin  5     Walter Reinisch     Byong Duk Ye     Stefan Schreiber    
1 Celltrion Healthcare,Incheon,Korea, Republic of
2 University Hospital Southampton NHS Foundation Trust,Southampton,United Kingdom
3 Guy’s and St Thomas’ Hospital,London,United Kingdom
4 Amsterdam University Medical Centers,Amsterdam,Netherlands
5 Chaim Sheba Medical Center and Sackler Schoo

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing